Targeted Therapies in Canine Hemangiosarcoma

Principal Investigator Cheryl London, DVM, PhD at Tufts University School of Medicine recently sent her Final Report on her grant "Identification of Novel Synthetic Lethal Partners to Optimize P13K Targeted Therapies in Canine Hemangiosarcoma".    

The American German Shepherd Dog Charitable Foundation helped fund this American Kennel Club Canine Health Foundation study.

To see the Research Final Report, please click here